Recommended Topic Related To:

Infanrix

"Jan. 7, 2013 -- Children whose dads were depressed during the pregnancy are more likely to exhibit emotional and behavioral problems at age 3, new research suggests.

The finding comes from an ongoing study of more than 30,000 Norwegia"...

Infanrix

Warnings
Precautions

WARNINGS

The tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber that may cause allergic reactions in latex sensitive individuals. The vial stopper is latex-free.

If Guillain-Barré syndrome occurs within 6 weeks of receipt of prior vaccine containing tetanus toxoid, the decision to give INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) should be based on careful consideration of the potential benefits and possible risks.5

If any of the following events occur in temporal relation to receipt of DTwP or a vaccine containing an acellular pertussis component, the decision to give INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) should be based on careful consideration of the potential benefits and possible risks:11,12

  • Temperature of ≥ 40.5°C (105°F) within 48 hours not due to another identifiable cause;
  • Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours;
  • Persistent, inconsolable crying lasting ≥ 3 hours, occurring within 48 hours;
  • Seizures with or without fever occurring within 3 days.

When a decision is made to withhold pertussis vaccine, immunization with DT vaccine should be given.2

The decision to administer a pertussis-containing vaccine to individuals with stable CNS disorders must be made by the physician on an individual basis, with consideration of all relevant factors, and assessment of potential risks and benefits for that individual. The Advisory Committee on Immunization Practices (ACIP) has issued guidelines for such individuals.11 The parent or guardian should be advised of the potential increased risk involved (see PRECAUTIONS, Information for Vaccine Recipients and Parents or Guardians).

A family history of seizures or other CNS disorders is not a contraindication to pertussis vaccine.11

For children at higher risk for seizures than the general population, an appropriate antipyretic may be administered at the time of vaccination with a vaccine containing an acellular pertussis component (including INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) ) and for the ensuing 24 hours according to the respective prescribing information recommended dosage to reduce the possibility of post-vaccination fever.5,11

The ACIP has published guidelines for vaccination of persons with recent or acute illness (www.cdc.gov).5

As with other intramuscular injections, INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) should not be given to infants or children with bleeding disorders such as hemophilia or thrombocytopenia, or to persons on anticoagulant therapy unless the potential benefit clearly outweighs the risk of administration. If the decision is made to administer INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) to such persons, it should be given with caution with steps taken to avoid the risk of hematoma following the injection.5

PRECAUTIONS

Before the injection of any biological, the physician should take all reasonable precautions to prevent allergic or other adverse reactions, including understanding the use of the biological concerned, and the nature of the side effects and adverse reactions that may follow its use.

Prior to immunization, the patient's current health status and medical history should be reviewed. The physician should review the patient's immunization history for possible vaccine sensitivity, previous vaccination-related adverse reactions, and occurrence of any adverse-event-related symptoms and/or signs, in order to determine the existence of any contraindication to immunization with INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) and to allow an assessment of benefits and risks. Epinephrine injection (1:1,000) and other appropriate agents used for the control of immediate allergic reactions must be immediately available should an acute anaphylactic reaction occur.

A separate sterile syringe and sterile disposable needle or a sterile disposable unit should be used for each individual patient to prevent transmission of hepatitis or other infectious agents from one person to another. Needles should be disposed of properly and should not be recapped.

Special care should be taken to prevent injection into a blood vessel.

As with any vaccine, if administered to immunosuppressed persons, including individuals receiving immunosuppressive therapy, the expected immune response may not be obtained.13

Carcinogenesis, Mutagenesis, Impairment of Fertility

INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

Pregnancy

Pregnancy Category C. INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) is not indicated for women of child-bearing age. Animal reproduction studies have not been conducted with INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) . It is not known whether INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) can cause fetal harm when administered to a pregnant woman or if INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) can affect reproductive capacity.

Geriatric Use

INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) is not indicated for use in adult populations.

Pediatric Use

Safety and effectiveness of INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) in infants younger than 6 weeks of age have not been evaluated. INFANRIX (diphtheria and tetanus toxoids and acellular pertussis) is not recommended for persons 7 years of age or older. Tetanus and Diphtheria Toxoids Adsorbed For Adult Use (Td) should be used in individuals 7 years of age or older.

REFERENCES

2. Centers for Disease Control. Diphtheria, tetanus, and pertussis: Recommendations for vaccine use and other preventive measures — Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-10):1-28.

5. Centers for Disease Control and Prevention. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 2002;51(RR-2):1-35.

11. Centers for Disease Control and Prevention. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children — Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-7):1-25.

12. Centers for Disease Control and Prevention. Update: Vaccine side effects, adverse reactions, contraindications, and precautions — Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR-12):1-35.

13. Centers for Disease Control and Prevention. Use of vaccines and immune globulins in persons with altered immunocompetence: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993;42(RR-4):1-18.

Last reviewed on RxList: 3/6/2009
This monograph has been modified to include the generic and brand name in many instances.

Warnings
Precautions
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Parenting and Pregnancy

Get tips for baby and you.


NIH talks about Ebola on WebMD